BTMDMICRO

biote Corp.

HealthcareMedical - Care Facilities
$2.25
$0.00(-1.32%)
52W$1.27
$4.75
Updated Jul 8, 02:00 AM
RSI57
RS Rating31/99
Beta1.32
Volatility68%
F-Score6/9
Mkt Cap$99M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

biote Corp. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 31), showing significant lag compared to the market leaders. Earnings contraction of 84% provides fundamental context to the price action. Investors should exercise caution due to high volatility (68% annualized), which requires wider risk management.

Relative Strength
31
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.32
vs S&P 500
ABOVE MKT
52W Position
28%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.14
50 SMA > 100 SMA$1.97
100 SMA > 150 SMA$2.14
150 SMA > 200 SMA$2.31

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.16+4.21%ABOVE
50 SMA$2.14+5.30%ABOVE
100 SMA$1.97+14.25%ABOVE
150 SMA$2.14+5.37%ABOVE
200 SMA$2.31-2.56%BELOW

Price Performance

1D-1.3%
1W+19.0%
1M-3.8%
3M+51.0%
6M-8.2%
YTD-8.9%
1Y-43.6%
3Y-29.4%
52-Week Trading Range28% from low
$2.25
52W Low$1.27
52W High$4.75

Technical Indicators

RSI (14)NEUTRAL
56.6
305070
Setup ScoreCOOL
1/10
Base depth: 44.4%

Risk Profile

Beta
1.32
52W Vol
68%
ATR
$0.19
Max DD (1Y)
-71%

Volume Analysis

Today
228.7K
50D Avg
229.1K
Vol Ratio
1.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+153%
$0.10
Q3'25-33%
$0.22
Q4'25-36%
$0.06
Q1'26-84%
$0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+10.52%
3 Years:+5.23%
TTM:-5.63%

Compounded Profit Growth

10 Years:
5 Years:-28.10%
3 Years:+66.61%
TTM:-27.23%

Stock Price CAGR

10 Years:-13.90%
5 Years:-25.34%
3 Years:-29.42%
1 Year:-43.61%

Return on Equity

10Y Avg:790.8%
5Y Avg:790.8%
3Y Avg:
Last Year:

Key Metrics

Market Cap$99M
Gross Margin71.5%
Net Margin14.1%
Piotroski F-Score6/9

Frequently Asked Questions

Is BTMD in an uptrend right now?

BTMD has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is BTMD overbought or oversold?

BTMD's RSI (14) is 57. The stock is in neutral territory, neither overbought nor oversold.

Is BTMD outperforming the market?

BTMD has a Relative Strength (RS) Rating of 31 out of 99. BTMD is currently lagging the broader market.

Where is BTMD in its 52-week range?

BTMD is trading at $2.25, which is 47% of its 52-week high ($4.75) and 28% above its 52-week low ($1.27).

How volatile is BTMD?

BTMD has a Beta of 1.32 and 52-week volatility of 68%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.